IDEAYA Biosciences, Inc. is a clinical-stage precision medicine oncology company revered for its efforts in oncology drug discovery. Operating globally, the company focuses on developing precision medicine targeting cancer vulnerabilities.
IDEAYA Biosciences, Inc. operates primarily in the healthcare sector, where it is committed to creating targeted therapeutics using molecular diagnostics. Its portfolio of pipeline programs includes darovasertib (IDE196), a clinical-stage PKC inhibitor for genetically defined cancers.
Find IDYA price updates and further information on eToro.